Salk Institute Cancer Center
GPTKB entity
Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:healthcare_organization
|
| gptkbp:affiliatedWith |
gptkb:Salk_Institute_for_Biological_Studies
|
| gptkbp:aimsTo |
understand cancer biology
|
| gptkbp:collaboratesWith |
pharmaceutical companies
various universities |
| gptkbp:conducts |
clinical trials
|
| gptkbp:director |
Professor
|
| gptkbp:engagesIn |
community outreach
|
| gptkbp:establishedIn |
2000
|
| gptkbp:focusesOn |
cancer research
|
| gptkbp:hasResearchInterest |
molecular biology
biochemistry genetics palliative care public health biomarkers cell biology cell signaling patient advocacy personalized medicine surgery bioinformatics health disparities biostatistics radiation therapy therapeutics epidemiology chemotherapy immunology immunotherapy targeted therapy tumor microenvironment translational research epigenetics health informatics cancer prevention cancer genomics metastasis therapeutic targets clinical ethics cancer stem cells therapeutic resistance clinical applications drug resistance healthcare_policy quality of life research preclinical models patient-derived xenografts |
| gptkbp:hosts |
scientific conferences
|
| https://www.w3.org/2000/01/rdf-schema#label |
Salk Institute Cancer Center
|
| gptkbp:is_funded_by |
gptkb:National_Institutes_of_Health
|
| gptkbp:locatedIn |
gptkb:La_Jolla,_California
|
| gptkbp:offers |
research programs
|
| gptkbp:partOf |
gptkb:Salk_Institute
|
| gptkbp:provides |
training programs
|
| gptkbp:publishes |
research findings
|
| gptkbp:receives |
private donations
|
| gptkbp:supports |
graduate students
|
| gptkbp:utilizes |
cutting-edge technology
|